Literature DB >> 17205528

HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation.

Se-Heon Kim1, Bon-Seok Koo, Suki Kang, Kyeongmee Park, Haeryoung Kim, Kyung Ryul Lee, Moo Joo Lee, Jong Man Kim, Eun Chang Choi, Nam Hoon Cho.   

Abstract

The prevalence of human papillomavirus (HPV) infection is high in the oropharyngeal mucosal regions, of which the tonsil is the most commonly affected. There may be a link between HPV and the pathogenesis of tonsillar cancer (TC), because of common anatomical characteristics between cervical and tonsillar cancer. We aimed to clarify whether HPV directly affects the oncogenesis and biologic behavior of TC by making a comparison between infection prevalence, physical status and viral loading numbers, and clinicopathologic prognostic factors. To compare HPV-related molecules between TC and tonsillitis (CFT), p16, survivin, HIF-1alpha, skp-1, cyclin A, cyclin B1, c-myc and EGFR were investigated. We observed a significant difference in HPV prevalence between 52 TCs and 69 CFTs (73.1% vs. 11.6%), and most of the HPVs were type 16 (87.2%) and nonepisomal (94.1%). Most TCs associated with HPV arose from the tonsillar crypts, and tended to be inverted and poorly differentiated. Compared with HPV-negative TC, HPV-positive TC showed a strong association with p16 overexpression (p<0.0001), and an inverse association with EGFR amplification (p=0.0478). HPV-16 integration status was strongly associated with c-myc amplification (p=0.034) and HIF-1alpha overexpression (p=0.022). HPV-16 integration could be directly related to tonsillar carcinogenesis initially in tonsillar crypts, followed by cell cycle aberration such as p16 overexpression related to the G1-S phase. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205528     DOI: 10.1002/ijc.22464

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  79 in total

1.  Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma.

Authors:  Rebecca D Chernock; James S Lewis; Qin Zhang; Samir K El-Mofty
Journal:  Hum Pathol       Date:  2010-03-17       Impact factor: 3.466

Review 2.  Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system.

Authors:  Margaret Brandwein-Gensler; Richard V Smith
Journal:  Head Neck Pathol       Date:  2010-02-06

Review 3.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

Review 4.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

5.  Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.

Authors:  Zhongchuan Will Chen; Ilan Weinreb; Suzanne Kamel-Reid; Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2012-07-17

6.  Nonkeratinizing Squamous Cell Carcinoma In Situ of the Upper Aerodigestive Tract: An HPV-Related Entity.

Authors:  Lingxin Zhang; James S Lewis; Samir K El-Mofty; Manoj Gandhi; Rebecca D Chernock
Journal:  Head Neck Pathol       Date:  2016-08-04

7.  APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.

Authors:  S Kondo; K Wakae; N Wakisaka; Y Nakanishi; K Ishikawa; T Komori; M Moriyama-Kita; K Endo; S Murono; Z Wang; K Kitamura; T Nishiyama; K Yamaguchi; S Shigenobu; M Muramatsu; T Yoshizaki
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

Review 8.  Treatment de-intensification strategies for head and neck cancer.

Authors:  Jacqueline R Kelly; Zain A Husain; Barbara Burtness
Journal:  Eur J Cancer       Date:  2016-10-15       Impact factor: 9.162

9.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.

Authors:  Solomon Jo; Agnes Juhasz; Keqiang Zhang; Christopher Ruel; Sofia Loera; Sharon P Wilczynski; Yun Yen; Xiyong Liu; Joshua Ellenhorn; Dean Lim; Benjamin Paz; George Somlo; Nayana Vora; Stephen Shibata
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

10.  HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome.

Authors:  Rebecca D Chernock; Samir K El-Mofty; Wade L Thorstad; Curtis A Parvin; James S Lewis
Journal:  Head Neck Pathol       Date:  2009-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.